EVOLVE BIOSYSTEMS
Evolve Biosystems is a biotechnology company that specializes in providing microbiome-based products designed to develop, restore, and maintain. The company's platform focuses on solving the gut dysbiosis throughout the human life cycle as well as in various animal species, enabling physicians to maintain the healthy gut microbiome in newborn infants with a consumer-directed home use product, and a hospital-based neonatal ICU product. It was founded in 2011 and headquartered in Davis, California.
EVOLVE BIOSYSTEMS
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2011-01-01
Address:
Davis, California, United States
Country:
United States
Website Url:
http://www.evolvebiosystems.com
Total Employee:
11+
Status:
Active
Contact:
+44 530 747 2012
Total Funding:
125 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag Microsoft Exchange Online Organization Schema
Similar Organizations
Weavr Health
Weavr Health is revolutionizing blood collection beyond the point of care including patients’ homes.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Grail
Grail develops a pan-cancer screening test designed to detect cancers at an early stage.
Gramercy Extremity Orthopedics
Gramercy Extremity Orthopedics specializes in providing inventory management, foot and ankle, implants, and product development.
NuPulseCV
NuPulse specializes in developing technology designed to treat patients with heart failure.
ProSomnus Sleep Technologies
ProSomnus designs and manufactures intraoral devices designed to help dentists get patients into therapy with comfort.
Current Advisors List
Board_member
2017-08-01
Board_observer
Board_member
2017-01-01
Current Employees Featured
Carlito Lebrilla Co-Founder @ Evolve Biosystems
Co-Founder
Daniela Barile Co-Founder @ Evolve Biosystems
Co-Founder
2011-08-01
Bruce German Co-Founder @ Evolve Biosystems
Co-Founder
David Kyle Chief Scientific Officer @ Evolve Biosystems
Chief Scientific Officer
2017-08-01
Samara Freeman Director, IP & Regulatory Affairs @ Evolve Biosystems
Director, IP & Regulatory Affairs
2016-01-01
Sandy Argabrite Chief Financial Officer @ Evolve Biosystems
Chief Financial Officer
David Mills Co-Founder @ Evolve Biosystems
Co-Founder
2011-08-01
Samara Freeman Founder @ Evolve Biosystems
Founder
2011-08-01
Founder
Investors List
Cargill
Cargill investment in Series D - Evolve Biosystems
Manna Tree
Manna Tree investment in Series D - Evolve Biosystems
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Series C - Evolve Biosystems
Horizon Ventures
Horizon Ventures investment in Series C - Evolve Biosystems
Spruce Capital Partners
Spruce Capital Partners investment in Series B - Evolve Biosystems
Tate & Lyle Ventures
Tate & Lyle Ventures investment in Series B - Evolve Biosystems
Horizons Ventures
Horizons Ventures investment in Series B - Evolve Biosystems
Acre Venture Partners
Acre Venture Partners investment in Series B - Evolve Biosystems
Bow Capital
Bow Capital investment in Series B - Evolve Biosystems
Tate & Lyle Ventures
Tate & Lyle Ventures investment in Series A - Evolve Biosystems
Official Site Inspections
http://www.evolvebiosystems.com Semrush global rank: 1.96 M Semrush visits lastest month: 10.97 K
Unable to get host informations!!!
More informations about "Evolve Biosystems"
Evolve Biosystems becomes Infinant Health
Infinant Health ("Infinant"), previously known as Evolve Biosystems, is committed to changing the trajectory of human health, one baby at a time. Infinant's key asset, EVC001, is a specific …See details»
Evolve Biosystems - Crunchbase Company Profile
Evolve Biosystems is a biotechnology company that specializes in providing microbiome-based products designed to develop, restore, and maintain. The company's platform focuses on solving the gut dysbiosis throughout the …See details»
Evolve BioSystems
Evolve BioSystems, Inc. is a privately-held infant health company dedicated to discovering and implementing microbiome-based solutions that recognize how infant diet and microbiome …See details»
Evolve Biosystems becomes Infinant Health - powerful …
NORWALK, Conn., Oct. 3, 2022 /PRNewswire/ -- Infinant Health ("Infinant Health" or the "Company"), a privately-held company focused on changing the trajectory of human health, one baby at a time ...See details»
Evolve BioSystems Becomes Infinant Health | Manna …
Oct 6, 2022 Infinant Health (“Infinant”), previously known as Evolve Biosystems, is committed to changing the trajectory of human health, one baby at a time. Infinant’s key asset, EVC001, is a specific strain of B. infantis and is vital to …See details»
Evolve Biosystems becomes Infinant Health - Markets …
NORWALK, Conn., Oct. 3, 2022 /PRNewswire/ -- Infinant Health ("Infinant Health" or the "Company"), a privately-held company focused on changing the trajectory of human health, one baby at a time ...See details»
Evolve BioSystems Inc - Company Profile and News
Evolve Biosystems, Inc., a life sciences company, develops and markets probiotic-based biotherapeutics to establish, restore, and maintain a healthy human microbiome across a …See details»
Evolve Biosystems - Funding, Financials, Valuation & Investors
Evolve Biosystems is funded by 9 investors. Cargill and Manna Tree are the most recent investors. Evolve Biosystems has a post-money valuation in the range of $100M to $500M as …See details»
Evolve Biosystems - Contacts, Employees, Board Members
Organization. Evolve Biosystems . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 7. ... Evolve …See details»
Evolve Biosystems Company Profile: Overview and Full News Analysis
Evolve BioSystems, Inc. is a global leader dedicated to improving human health through the gut microbiome . The study will assess the effects of introducing a specific gut bacterium, …See details»
Evolve BioSystems Announces Major Strategic …
DAVIS, Calif., Feb. 8, 2021 /PRNewswire/ -- Evolve BioSystems announced today that it completed a substantial first close in a $55 million Series D round of funding, led by Cargill, the global ...See details»
Evolve Biosystems becomes Infinant Health - BioSpace
Oct 3, 2022 Infinant Health (“Infinant”), previously known as Evolve Biosystems, is committed to changing the trajectory of human health, one baby at a time. Infinant’s key asset, EVC001, is a …See details»
Evolve BioSystems Announces Major Strategic Investment from
DAVIS, Calif., Feb. 8, 2021 /PRNewswire/ -- Evolve BioSystems announced today that it completed a substantial first close in a $55 million Series D round of funding, led by Cargill, the …See details»
Evolve BioSystems gets $55 million investment led by Cargill
Feb 10, 2021 Evolve Biosystems is an independent microbiome research company that was launched out of University of California, Davis in 2014. It was initially funded by the Bill & …See details»
Evolve BioSystems Announces $40 Million Series C Financing to …
Jun 14, 2018 Evolve BioSystems, Inc., the leading infant gut microbiome company, today announced that it has completed a $40 million Series C round of funding co-led by the Bill & …See details»
Chief Scientific Officer @ Evolve Biosystems - Crunchbase
David Kyle is the CEO of Evolve Biosystems Inc., a spin-off of the University of California at Davis. He founded several companies during his career, including Martek Biosciences where …See details»
Evolve BioSystems Announces $40 Million Series C Financing to …
DAVIS, Calif., June 13, 2018 /PRNewswire/ -- Evolve BioSystems, Inc., the leading infant gut microbiome company, today announced that it has completed a $40 million Series C round of …See details»
Evolve BioSystems Inc. Completes $9 Million Series A Investment
Aug 17, 2015 Evolve BioSystems, Inc., a microbiotics company developing novel solutions to resolve the dysbiosis in the human infant microbiome that can result from pre-term birth, …See details»
Evolve BioSystems announces investment from Cargill and Manna …
Feb 15, 2021 US microbiome company Evolve BioSystems has announced that it completed a first close in a $55m Series D round of funding, led by Cargill, the global food, agricultural, …See details»
Sacco System supports Evivo®, the Baby Probiotic
Sep 15, 2021 Evolve BioSystems, Inc. is the manufacturer of Evivo ®, a proprietary groundbreaking probiotic proven to resolve Newborn Gut Deficiency, proven by several …See details»